This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Matthew M Bio
Introduction
Matthew M Bio is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of ribonucleosides. His work is essential in advancing treatments for viral infections, specifically hepatitis C.
Latest Patents
Matthew holds a patent for a process titled "Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates." This innovative process allows for the preparation of branched-chain ribonucleosides, which are crucial in inhibiting HCV polymerase. The compounds developed through this process are valuable in the treatment of HCV infection. He has 1 patent to his name.
Career Highlights
Matthew is currently employed at Merck & Co., Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in biochemistry and innovative thinking have made him a key player in his field.
Collaborations
Matthew has collaborated with talented coworkers such as Feng Xu and Cameron Cowden. Their combined efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Matthew M Bio's contributions to the field of biochemistry and his innovative patent work highlight his importance as an inventor. His ongoing research at Merck & Co., Inc. continues to pave the way for new treatments in the fight against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile